Regranex er blevet undersøgt i fire kliniske undersøgelser af 20 ugers varighed hos voksne sukkersygepatienter, der har haft mindst ét diabetisk sår i mindst 8 uger (samlet antal sår:
Regranex has been studied in 4 clinical trials, lasting 20 weeks, in diabetic adults who had been suffering from at least one diabetic ulcer for at least 8 weeks (total number of ulcers: